Rutika Mehta
Medical oncologist at Weill Cornell Medicine/NewYork-Presbyterian who focuses on immunotherapy strategies for gastroesophageal cancers and provides practical management insights for community oncologists.
Best podcasts with Rutika Mehta
Ranked by the Snipd community
Apr 3, 2026 • 22min
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr John Strickler, Duke medical oncologist who researches targeted agents like claudin 18.2. Dr Rutika Mehta, Weill Cornell oncologist focused on immunotherapy strategies and practical management. Dr Jaffer Ajani, MD Anderson investigator known for zolbetuximab work. They discuss dosing tweaks to reduce toxicity, strategies for managing nausea and anticoagulation, biomarker prioritization, and chemo–immunotherapy selection.
Dec 15, 2025 • 15min
Current Treatment Landscape of Advanced Gastric/Esophageal/GEJ Adenocarcinoma – Dr. Rutika Mehta
Dr. Rutika Mehta, a GI medical oncologist at Weill Cornell, shares her expertise on advanced gastroesophageal cancers. She discusses the recent approval of durvalumab for resectable disease and the critical role of biomarker testing, particularly HER2, in treatment decisions. Insights into frontline therapies for HER2-positive patients and the significance of retesting HER2 upon disease progression are highlighted. Emerging treatments like TDXd and Zanidatamab also get attention, alongside considerations for managing side effects and treatment sequencing.
